These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24330408)

  • 1. Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report.
    Reininghaus EZ; McIntyre RS; Reininghaus B; Geisler S; Bengesser SA; Lackner N; Hecht K; Birner A; Kattnig F; Unterweger R; Kapfhammer HP; Zelzer S; Fuchs D; Mangge H
    Bipolar Disord; 2014 Jun; 16(4):432-40. PubMed ID: 24330408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tryptophan metabolism and food craving in the relationship between obesity and bipolar disorder.
    Dalkner N; Platzer M; Bengesser SA; Birner A; Fellendorf FT; Queissner R; Painold A; Mangge H; Fuchs D; Reininghaus B; Kapfhammer HP; Holasek SJ; Reininghaus EZ
    Clin Nutr; 2018 Oct; 37(5):1744-1751. PubMed ID: 28712531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan Metabolism in Bipolar Disorder in a Longitudinal Setting.
    Fellendorf FT; Gostner JM; Lenger M; Platzer M; Birner A; Maget A; Queissner R; Tmava-Berisha A; Pater CA; Ratzenhofer M; Wagner-Skacel J; Bengesser SA; Dalkner N; Fuchs D; Reininghaus EZ
    Antioxidants (Basel); 2021 Nov; 10(11):. PubMed ID: 34829665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder.
    Mukherjee D; Krishnamurthy VB; Millett CE; Reider A; Can A; Groer M; Fuchs D; Postolache TT; Saunders EFH
    Bipolar Disord; 2018 Feb; 20(1):27-34. PubMed ID: 28833866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
    Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
    PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
    Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D
    Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
    Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
    Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome.
    Mangge H; Summers KL; Meinitzer A; Zelzer S; Almer G; Prassl R; Schnedl WJ; Reininghaus E; Paulmichl K; Weghuber D; Fuchs D
    Obesity (Silver Spring); 2014 Jan; 22(1):195-201. PubMed ID: 23625535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients.
    Brandacher G; Winkler C; Aigner F; Schwelberger H; Schroecksnadel K; Margreiter R; Fuchs D; Weiss HG
    Obes Surg; 2006 May; 16(5):541-8. PubMed ID: 16687019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan degradation in patients with gynecological cancer correlates with immune activation.
    Schroecksnadel K; Winkler C; Fuith LC; Fuchs D
    Cancer Lett; 2005 Jun; 223(2):323-9. PubMed ID: 15896467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder.
    Poletti S; Melloni E; Aggio V; Colombo C; Valtorta F; Benedetti F; Comai S
    J Affect Disord; 2019 Dec; 259():404-412. PubMed ID: 31610997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
    Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan breakdown and cognition in bipolar disorder.
    Platzer M; Dalkner N; Fellendorf FT; Birner A; Bengesser SA; Queissner R; Kainzbauer N; Pilz R; Herzog-Eberhard S; Hamm C; Hörmanseder C; Maget A; Rauch P; Mangge H; Fuchs D; Zelzer S; Schütze G; Moll N; Schwarz MJ; Mansur RB; McIntyre RS; Reininghaus EZ
    Psychoneuroendocrinology; 2017 Jul; 81():144-150. PubMed ID: 28482311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age.
    Frick B; Schroecksnadel K; Neurauter G; Leblhuber F; Fuchs D
    Clin Biochem; 2004 Aug; 37(8):684-7. PubMed ID: 15302611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan metabolism in post-withdrawal alcohol-dependent patients.
    Gleissenthall GV; Geisler S; Malik P; Kemmler G; Benicke H; Fuchs D; Mechtcheriakov S
    Alcohol Alcohol; 2014; 49(3):251-5. PubMed ID: 24644258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers.
    Sperner-Unterweger B; Neurauter G; Klieber M; Kurz K; Meraner V; Zeimet A; Fuchs D
    Immunobiology; 2011 Mar; 216(3):296-301. PubMed ID: 20822828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
    Gostner JM; Obermayr E; Braicu IE; Concin N; Mahner S; Vanderstichele A; Sehouli J; Vergote I; Fuchs D; Zeillinger R
    Gynecol Oncol; 2018 May; 149(2):371-380. PubMed ID: 29530331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis.
    Schroecksnadel K; Kaser S; Ledochowski M; Neurauter G; Mur E; Herold M; Fuchs D
    J Rheumatol; 2003 Sep; 30(9):1935-9. PubMed ID: 12966593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
    Widner B; Leblhuber F; Fuchs D
    J Neural Transm (Vienna); 2002 Feb; 109(2):181-9. PubMed ID: 12075858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.